Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Interest Expenses (2023 - 2025)

Tandem Diabetes Care's Interest Expenses history spans 3 years, with the latest figure at $2.1 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 11.56% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $7.9 million, up 6.64%, while the annual FY2025 figure was $7.9 million, 6.64% up from the prior year.
  • Interest Expenses reached $2.1 million in Q4 2025 per TNDM's latest filing, roughly flat from $2.1 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $4.8 million in Q3 2023 to a low of $1.6 million in Q2 2023.
  • Average Interest Expenses over 3 years is $2.1 million, with a median of $1.9 million recorded in 2024.
  • The largest YoY upside for Interest Expenses was 11.71% in 2024 against a maximum downside of 61.47% in 2024.
  • A 3-year view of Interest Expenses shows it stood at $1.8 million in 2023, then grew by 3.16% to $1.9 million in 2024, then increased by 11.56% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Interest Expenses are $2.1 million (Q4 2025), $2.1 million (Q3 2025), and $1.9 million (Q2 2025).